Stock listing

OTC:RMTG Regenerative Medical Technology Group Inc. Stock

Follow Regenerative Medical Technology Group Inc. into a list and get an email when it puts out news.

Share price · OTC:RMTG

$0.04 USD +0.00 (+6.1%)

Close on Oct 16, 2026

Since Jul 6, 2026 +39.5% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$0.04 – $0.04 USDOct 16, 2026
Volume
2,751 sharesOct 16, 2026
Market value
$548,184 USDAt the close on Oct 16, 2026 · price × 13.74M shares outstanding
Regenerative Medical Technology Group Inc. logo
Ticker
OTC:RMTG
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks

Oct 8, 2026

RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies

Oct 5, 2026

RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides

Oct 1, 2026

RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico

Sep 21, 2026

RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy

Sep 17, 2026

Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model

Sep 14, 2026

RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements

Sep 8, 2026

Cellgenic Establishes Local Commercial Presence in Brazil

Sep 3, 2026

RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint

Sep 1, 2026

RMTG's Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions

Aug 27, 2026

All Regenerative Medical Technology Group Inc. news

Regenerative Medical Technology Group Inc. on 6ix

News releases
23 in the last 12 months · 213 in all · newest Oct 8, 2026 · oldest 2009

Log in to ask 6ix AI your own questions about Regenerative Medical Technology Group Inc.